The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
Open accessAbstract
Glioblastoma remains one of the most lethal types of cancer, and is the most common brain tumour in adults. In particular, tumour recurrence after surgical resection and radiation invariably occurs regardless of aggressive chemotherapy. Here, we provide evidence that the transcription factor ZEB1 (zinc finger E-box binding homeobox 1) exerts simultaneous influence over invasion, chemoresistance and tumourigenesis in glioblastoma. ZEB1 is preferentially expressed in invasive glioblastoma cells, where the ZEB1-miR-200 feedback loop interconnects these processes through the downstream effectors ROBO1, c-MYB and MGMT. Moreover, ZEB1 expression in glioblastoma patients is predictive of shorter survival and poor Temozolomide response. Our findings indicate that this regulator of epithelial-mesenchymal transition orchestrates key features of cancer stem cells in malignant glioma and identify ROBO1, OLIG2, CD133 and MGMT as novel targets of the ZEB1 pathway. Thus, ZEB1 is an important candidate molecule for glioblastoma recurrence, a marker of invasive tumour cells and a potential therapeutic target, along with its downstream effectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,699
Self-citationBone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Self-citationIgnatova, T. N., Kukekov, V. G., Laywell, E. D., Suslov, O. N., Vrionis, F. D., & Steindler, D. A. (2002) · Glia · doi:10.1002/glia.10094 · Cited by 992
Self-citationVescovi, A. L., Galli, R., & Reynolds, B. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1889 · Cited by 990
Self-citationEpidemiology and molecular pathology of glioma
Schwartzbaum, J. A., Fisher, J. L., Aldape, K. D., & Wrensch, M. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0289 · Cited by 949
Molecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847
MGMT: its role in cancer aetiology and cancer therapeutics
Gerson, S. L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1319 · Cited by 813
Bleau, A.-M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., & Holland, E. C. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.007 · Cited by 808
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Self-citationE-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9179-y · Cited by 765
Self-citationMurat, A., Migliavacca, E., Gorlia, T., Lambiv, W. L., Shay, T., Hamou, M.-F., de Tribolet, N., Regli, L., Wick, W., Kouwenhoven, M. C. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7164 · Cited by 721
Wang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4312 · Cited by 619
Gangemi, R. M. R., Griffero, F., Marubbi, D., Perera, M., Capra, M. C., Malatesta, P., Ravetti, G. L., Zona, G. L., Daga, A., & Corte, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0493 · Cited by 578
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Lu, K. V., Chang, J. P., Parachoniak, C. A., Pandika, M. M., Aghi, M. K., Meyronet, D., Isachenko, N., Fouse, S. D., Phillips, J. J., Cheresh, D. A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.037 · Cited by 550
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Chen, R., Nishimura, M. C., Bumbaca, S. M., Kharbanda, S., Forrest, W. F., Kasman, I. M., Greve, J. M., Soriano, R. H., Gilmour, L. L., Rivers, C. S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.049 · Cited by 544
Brennan, C., Momota, H., Hambardzumyan, D., Ozawa, T., Tandon, A., Pedraza, A., & Holland, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007752 · Cited by 534
Lefranc, F., Brotchi, J., & Kiss, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.089 · Cited by 526
Ligon, K. L., Huillard, E., Mehta, S., Kesari, S., Liu, H., Alberta, J. A., Bachoo, R. M., Kane, M., Louis, D. N., DePinho, R. A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.009 · Cited by 501
Dichotomy of astrocytoma migration and proliferation
Giese, A., Loo, M. A., Tran, N., Haskett, D., Coons, S. W., & Berens, M. E. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960717)67:2<275::aid-ijc20>3.0.co;2-9 · Cited by 399
Molecular targets of glioma invasion
Nakada, M., Nakada, S., Demuth, T., Tran, N. L., Hoelzinger, D. B., & Berens, M. E. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6342-5 · Cited by 387
Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment
Hoelzinger, D. B., Demuth, T., & Berens, M. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm187 · Cited by 372
IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
Li, Y., Wang, L., Pappan, L., Galliher-Beckley, A., & Shi, J. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-87 · Cited by 319
Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation.
Clarke, M. F., Kukowska-Latallo, J. F., Westin, E., Smith, M., & Prochownik, E. V. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.884 · Cited by 298
TWIST1 promotes invasion through mesenchymal change in human glioblastoma
Mikheeva, S. A., Mikheev, A. M., Petit, A., Beyer, R., Oxford, R. G., Khorasani, L., Maxwell, J.-P., Glackin, C. A., Wakimoto, H., González-Herrero, I., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-194 · Cited by 289
Deadly Teamwork: Neural Cancer Stem Cells and the Tumor Microenvironment
Lathia, J. D., Heddleston, J. M., Venere, M., & Rich, J. N. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.04.013 · Cited by 273
Facchino, S., Abdouh, M., Chatoo, W., & Bernier, G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1634-10.2010 · Cited by 253
Molecular subclassification of diffuse gliomas: Seeing order in the chaos
Huse, J. T., Phillips, H. S., & Brennan, C. W. (2011) · Glia · doi:10.1002/glia.21165 · Cited by 233
Kahlert, U. D., Maciaczyk, D., Doostkam, S., Orr, B. A., Simons, B., Bogiel, T., Reithmeier, T., Prinz, M., Schubert, J., Niedermann, G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.024 · Cited by 231
Self-citationElevated invasive potential of glioblastoma stem cells
Cheng, L., Wu, Q., Guryanova, O. A., Huang, Z., Huang, Q., Rich, J. N., & Bao, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.123 · Cited by 199
Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
Lewis-Tuffin, L. J., Rodriguez, F., Giannini, C., Scheithauer, B., Necela, B. M., Sarkaria, J. N., & Anastasiadis, P. Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013665 · Cited by 188
Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion
Rhee, J., Mahfooz, N. S., Arregui, C., Lilien, J., Balsamo, J., & VanBerkum, M. F. A. (2002) · Nature Cell Biology · doi:10.1038/ncb858 · Cited by 183
Evidence for label-retaining tumour-initiating cells in human glioblastoma
Deleyrolle, L. P., Harding, A., Cato, K., Siebzehnrubl, F. A., Rahman, M., Azari, H., Olson, S., Gabrielli, B., Osborne, G., Vescovi, A., et al. (2011) · Brain · doi:10.1093/brain/awr081 · Cited by 182
Self-citationCancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy
Venere, M., Fine, H. A., Dirks, P. B., & Rich, J. N. (2011) · Glia · doi:10.1002/glia.21185 · Cited by 176
Ohashi, S., Natsuizaka, M., Wong, G. S., Michaylira, C. Z., Grugan, K. D., Stairs, D. B., Kalabis, J., Vega, M. E., Kalman, R. A., Nakagawa, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4614 · Cited by 164
Pathway inhibition: emerging molecular targets for treating glioblastoma
Wick, W., Weller, M., Weiler, M., Batchelor, T. T., Yung, A. W. K., & Platten, M. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor039 · Cited by 145
Residual tumor cells are unique cellular targets in glioblastoma
Glas, M., Rath, B. H., Simon, M., Reinartz, R., Schramme, A., Trageser, D., Eisenreich, R., Leinhaas, A., Keller, M., Schildhaus, H., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22036 · Cited by 143
Self-citationMultifaceted resistance of gliomas to temozolomide.
Bocangel, D., Finkelstein, S. D., Schold, S. C., Bhakat, K. K., MITRA, S. P., & Kokkinakis, D. M. (2002) · PubMed · Cited by 135
Object-oriented Transcription Factors Database (ooTFD)
GHOSH, D. K. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.308 · Cited by 131
Effect of Brain- and Tumor-Derived Connective Tissue Growth Factor on Glioma Invasion
Edwards, L., Woolard, K., Son, M. J., Li, A., Lee, J., Ene, C. I., Mantey, S. A., Maric, D., Song, H., Belova, G. I., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr224 · Cited by 123
Slit2 involvement in glioma cell migration is mediated by Robo1 receptor
Mertsch, S., Schmitz, N., Jeibmann, A., Geng, J.-G., Paulus, W., & Senner, V. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9484-2 · Cited by 120
Correlation of N-cadherin expression in high grade gliomas with tissue invasion
Asano, K., Asano, K., Duntsch, C. D., Zhou, Q., Weimar, J. D., Bordelon, D., Robertson, J. H., & Pourmotabbed, T. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000040811.14908.f2 · Cited by 120
Utsuki, S., Sato, Y., Oka, H., Tsuchiya, B., Suzuki, S., & Fujii, K. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015720220602 · Cited by 100
The origins of glioma: E Pluribus Unum?
Siebzehnrübl, F. A., Reynolds, B. A., Vescovi, A. L., Steindler, D. A., & Deleyrolle, L. P. (2011) · Glia · doi:10.1002/glia.21143 · Cited by 92
Self-citationGlioblastoma: the past, the present, and the future.
Wilson, C. B. (1992) · PubMed · Cited by 64
Glioma Migration: Clues from the Biology of Neural Progenitor Cells and Embryonic CNS Cell Migration
Dirks, P. B. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012273922478 · Cited by 56
Spontaneous In Vitro Transformation of Adult Neural Precursors into Stem‐Like Cancer Cells
Siebzehnrübl, F. A., Jeske, I., Müller, D., Buslei, R., Coras, R., Hahnen, E., Huttner, H. B., Corbeil, D., Kaesbauer, J., Appl, T., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00189.x · Cited by 42
Rhee, J., Mahfooz, N. S., Arregui, C. O., Lilien, J. E., Balsamo, J., & VanBerkum, M. F. A. (2002) · Cited by 35
Pardo, C. E., Carr, I., Hoffman, C. J., Darst, R. P., Markham, A. F., Bonthron, D. T., & Kladde, M. P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq716 · Cited by 32
Self-citationZheng, T., Marshall, G. P., Laywell, E. D., & Steindler, D. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.051 · Cited by 19
Self-citationHölsken, A., Eyüpoglu, I. Y., Lueders, M., Tränkle, C., Dieckmann, D., Buslei, R., Hahnen, E., Blümcke, I., & Siebzehnrübl, F. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0082-8 · Cited by 15
Cited by
Drug resistance and combating drug resistance in cancer
Wang, X., Zhang, H., & Chen, X. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.10 · Cited by 1,085
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Nassar, D., & Blanpain, C. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044438 · Cited by 869
Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Du, B., & Shim, J. (2016) · Molecules · doi:10.3390/molecules21070965 · Cited by 807
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Ye, X., Tam, W. L., Shibue, T., Kaygusuz, Y., Reinhardt, F., Ng Eaton, E., & Weinberg, R. A. (2015) · Nature · doi:10.1038/nature14897 · Cited by 694
Metadata
- Authors
- Siebzehnrubl, F. A., Silver, D. J., Tugertimur, B., Deleyrolle, L. P., Siebzehnrubl, D., Sarkisian, M. R., Devers, K. G., Yachnis, A. T., Kupper, M. D., Neal, D., Nabilsi, N. H., Kladde, M. P., Suslov, O., Brabletz, S., Brabletz, T., Reynolds, B. A., & Steindler, D. A.
- Venue
- EMBO Molecular Medicine
- Published
- 2013-07
- Volume
- 5
- Issue
- 8
- Pages
- 1196-1212
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2123434257
- Cited by
- 381
- References
- 65
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.